{
	"kihkckveText": "Anh<span class=\"_ _1\"></span>edon<span class=\"_ _1\"></span>ia is a c<span class=\"_ _1\"></span>omm<span class=\"_ _1\"></span>on sympto<span class=\"_ _1\"></span>m of MDD <br>r<span class=\"_ _1\"></span>eported i<span class=\"_ _1\"></span>n ~<span class=\"_ _3\"></span>7<span class=\"_ _2\"></span>5<span class=\"_ _1\"></span>% of p<span class=\"_ _1\"></span>atien<span class=\"_ _1\"></span>t<span class=\"_ _4\"></span>s<span class=\"_ _1\"></span><span class=\"fs3 v1\">1</span>",
	"kihkckvfText": "Anticipatory ",
	"kihkckvgText": "pleasure:",
	"kihkckvhText": " “wanting”",
	"kihkckviText": "relates to ",
	"kihkckvjText": "motivation",
	"kihkckvkText": "Consummatory ",
	"kihkckvlText": "pleasure:",
	"kihkckvmText": "“liking”",
	"kihkckvnText": "corresponds ",
	"kihkckvoText": "with experience ",
	"kihkckvpText": "of pleasure",
	"kihkckvqText": "Anhedonia:",
	"kihkckvrText": "Defined as an impaired ",
	"kihkckvsText": "capacity to experience <br>or anticipate pleasur<span class=\"_ _1\"></span>e<span class=\"fs14 v4\">1,2</span>",
	"kihkckvtText": "Characterised by a ",
	"kihkckvuText": "loss of interest and / or ",
	"kihkckvvText": "pleasure in pr<span class=\"_ _1\"></span>eviously ",
	"kihkckvwText": "enjoyable activities<span class=\"fs14 v4\">3</span>",
	"kihkckvxText": "See Brin<span class=\"_ _4\"></span>tellix® dat<span class=\"_ _4\"></span>a",
	"kihkckvyText": "Disease<span class=\"_ _f\"> </span><span class=\"ls13 wsb\">ST<span class=\"_ _1\"></span>AR*D<span class=\"_ _8\"></span><span class=\"ls0 ws0\">T<span class=\"_ _1\"></span>reatment Goals<span class=\"_ _9\"> </span><span class=\"ls13\">Adverse events<span class=\"_ _1b\"> </span>Emotional blunting<span class=\"_ _b\"></span>Cognitive Symptoms<span class=\"_ _c\"> </span>Cognitive Symptoms in Asia<span class=\"_ _1c\"> </span><span class=\"ff1 fc1\">Anhedonia</span></span></span></span>",
	"Brintellix_87ee6f03c": "<span style=\"color: rgb(77, 127, 134); font-family: '15_VDWFON+AvenirNextLTPro-Demi';\"><font style=\"font-size: 25px;\">References</font></span>",
	"Brintellix_82be8bce5": "<font style=\"font-size: 15px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nPan Z et al. Curr Pharm Des 2017;23:2065-2072.\n</font>",
	"Brintellix_8447ac160": "",
	"Brintellix_8021e2438": "",
	"Brintellix_868aeeded": "",
	"Brintellix_85c096451": "<font style=\"font-size: 15px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1;display:inline-block;\">\nFranken IHA et al. J Affect Disord 2007;99:83-89.\n</font>",
	"Brintellix_894561506": "<font style=\"font-size: 15px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nAmerican Psychiatric Association. Diagnostical and Statistical Manual for Mental Disorders,\n    Fifth Edition (DSM-5). 2013.\n</font>",
	"Brintellix_8f28d736c": "<font style=\"font-size: 15px; font-family: '2_VDWFON+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b>1.</b></font>",
	"Brintellix_812073ef2": "<font style=\"font-size: 15px; font-family: '2_VDWFON+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b>2.</b></font>",
	"Brintellix_8690ca923": "<font style=\"font-size: 15px; font-family: '2_VDWFON+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b>3.</b></font>",
	"Brintellix_85c331490": "Text",
	"Brintellix_88136d8f2": "Text",
	"Brintellix_816a41395": "Text",
	"Brintellix_8273d4034": "Text",
	"Brintellix_8ae57da94": "Text",
	"Brintellix_8aa6c560c": "Text",
	"Brintellix_8cf825902": "Text",
	"Brintellix_84fbcf947": "<div style=\"font-family: '2_ANALJY+AvenirNextLTPro-Demi';color: #fff;text-align: center;font-size: 17.5px;box-sizing: border-box;padding-top: 15px;\">Patient and HCP Perspectives</div>"
}
